A S Lok

Author PubWeight™ 93.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 1987 3.65
2 Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998 2.19
3 Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer 1988 1.83
4 Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology 1999 1.80
5 Clear cell carcinoma of liver. An ultrastructural study. Cancer 1983 1.72
6 Management of hepatitis C patients by primary care physicians in the USA: results of a national survey. J Viral Hepat 2001 1.70
7 Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology 2000 1.69
8 Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology 1993 1.63
9 Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children. Pediatr Nephrol 1992 1.44
10 Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma. J Hepatol 1985 1.43
11 Synergism of chronic alcoholism and hepatitis B infection in liver disease. J Gastroenterol Hepatol 1991 1.40
12 Granulocytic sarcoma presenting as bleeding gastric polyp. Pathology 1989 1.40
13 Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers. Gut 1983 1.40
14 Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001 1.34
15 Sucralfate overcomes adverse effect of cigarette smoking on duodenal ulcer healing and prolongs subsequent remission. Gastroenterology 1987 1.33
16 Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology 1990 1.31
17 Occult hepatitis B virus infection: a hidden menace? Hepatology 2001 1.26
18 High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection. Hepatology 1996 1.25
19 Hepatitis B virus infection in Chinese families in Hong Kong. Am J Epidemiol 1987 1.24
20 Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children. Lancet 1987 1.20
21 Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci 1991 1.20
22 Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis. Dig Dis Sci 1987 1.18
23 Hepatitis B infection in patients with lymphomas. Hematol Oncol 1991 1.12
24 Current seroepidemiology of hepatitis A in Hong Kong. J Med Virol 1991 1.12
25 Naturally occurring hepatitis B virus core gene mutations. Hepatology 1995 1.10
26 Mutations in the hepatitis B virus polymerase gene associated with antiviral treatment for hepatitis B. J Viral Hepat 1999 1.10
27 Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q J Med 1989 1.09
28 Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer. Hepatology 1997 1.05
29 Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease. J Hepatol 1985 1.04
30 A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication. Hepatology 1985 1.02
31 Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen. Br Med J (Clin Res Ed) 1985 1.02
32 Acute liver failure due to hepatic involvement by hematologic malignancy. Dig Dis Sci 1997 1.00
33 Detection of precore hepatitis B virus mutants in asymptomatic HBsAg-positive family members. Hepatology 1994 0.99
34 Current practice patterns of primary care physicians in the management of patients with hepatitis C. Hepatology 1999 0.99
35 Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection. Gut 1985 0.98
36 Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection. Gut 1984 0.96
37 Precore sequence variation in Chinese isolates of hepatitis B virus. J Infect Dis 1992 0.96
38 Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial. Br J Cancer 1989 0.95
39 Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication. Liver 1984 0.93
40 Hepatitis B infection in patients with acute liver failure in the United States. Hepatology 2001 0.93
41 Interferon therapy of chronic hepatitis B virus infection in Chinese. J Hepatol 1986 0.92
42 Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection. J Antimicrob Chemother 1984 0.92
43 Iron overload in patients with chronic hepatitis C: a clinicopathologic study. Hum Pathol 1996 0.92
44 Greater diversity of hepatitis C virus genotypes found in Hong Kong than in mainland China. J Clin Microbiol 1995 0.91
45 Hepatocellular carcinoma in Chinese males and females. Possible causes for the male predominance. Cancer 1987 0.89
46 The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre. Aliment Pharmacol Ther 2009 0.89
47 Apoplectic intracerebral hemorrhage: an unusual complication of cerebral radiation necrosis. Pathology 1987 0.87
48 A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 1993 0.87
49 Studies of HBV replication during acute hepatitis followed by recovery and acute hepatitis progressing to chronic disease. J Hepatol 1985 0.86
50 The immunopathology of autoimmune and hepatitis B virus-induced chronic hepatitis. Semin Liver Dis 1984 0.86
51 Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology 1995 0.85
52 High degree of conservation in the hepatitis B virus core gene during the immune tolerant phase in perinatally acquired chronic hepatitis B virus infection. J Hepatol 1997 0.85
53 Efficacy of sucralfate in corpus, prepyloric, and duodenal ulcer-associated gastric ulcers. A double-blind, placebo-controlled study. Am J Med 1985 0.85
54 Re-evaluation of alpha-interferon treatment of chronic hepatitis B using polymerase chain reaction. J Hepatol 1993 0.84
55 Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring--predictors and predictive models of disease progression. Aliment Pharmacol Ther 2014 0.84
56 Chronic antral gastritis in duodenal ulcer. Natural history and treatment with prostaglandin E1. Gastroenterology 1986 0.84
57 Haemodynamic responses to intravenous cimetidine in subjects with normal lung function and in subjects with chronic airway obstruction. Br J Clin Pharmacol 1981 0.83
58 Antiviral-resistant hepatitis B virus: can we prevent this monster from growing? J Viral Hepat 2007 0.83
59 Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patients. Hepatology 2001 0.83
60 Role of antiviral therapy in the prevention of perinatal transmission of hepatitis B virus infection. J Viral Hepat 2008 0.83
61 Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori. Am J Med 1989 0.83
62 Naturally occurring core-gene-defective hepatitis B viruses. J Gen Virol 1995 0.82
63 Hepatitis C infection among dialysis patients: a comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991 0.82
64 The diagnostic value of the ratio of serum gamma-glutamyl transpeptidase to alkaline phosphatase in alcoholic liver disease. Scand J Gastroenterol 1982 0.82
65 A randomized comparative study of laser photocoagulation, heater probe, and bipolar electrocoagulation in the treatment of actively bleeding ulcers. Gastrointest Endosc 1991 0.82
66 Recovery from chronic hepatitis B. Ann Intern Med 1992 0.82
67 Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Dig Dis Sci 1996 0.82
68 Analysis of the molecular state of HBV-DNA in the liver and serum of patients with chronic hepatitis or primary liver cell carcinoma and the effect of therapy with adenine arabinoside. Gut 1984 0.82
69 Influence of sexual preference and chronic hepatitis B virus infection on T lymphocyte subsets, natural killer activity, and suppressor cell activity. J Hepatol 1986 0.80
70 Psychosocial impact of chronic infection with hepatitis B virus on British patients. Genitourin Med 1985 0.80
71 Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg. Hepatology 1993 0.80
72 Interferon treatment for hepatitis C virus infection in patients on haemodialysis. Nephrol Dial Transplant 1997 0.80
73 Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group. J Viral Hepat 1994 0.80
74 Changes in characteristics of hepatitis C patients seen in a liver centre in the United States during the last decade. J Viral Hepat 2014 0.80
75 Prostaglandin E1 (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing. Dig Dis Sci 1986 0.79
76 Chronic hepatitis C after renal transplantation. Treatment with alpha-interferon. Transplantation 1993 0.79
77 Integration of HBV-DNA may not be a prerequisite for the maintenance of the state of malignant transformation. An analysis of 110 liver biopsies. J Hepatol 1986 0.78
78 A randomised controlled trial of recombinant interferon-gamma in Chinese patients with chronic hepatitis B virus infection. J Med Virol 1991 0.78
79 Mitozantrone as single agent therapy in hepatocellular carcinoma. A phase II study. J Hepatol 1985 0.78
80 Maintenance therapy for duodenal ulcer: a randomized controlled comparison of seven forms of treatment. Am J Med 1992 0.77
81 Correlation between serum HCV RNA and aminotransferase levels in patients with chronic HCV infection. Dig Dis Sci 1996 0.77
82 Approaches to the treatment of chronic hepatitis B viral infection. Prog Clin Biol Res 1983 0.77
83 Clinicopathological features of hepatitis C virus antibody negative fatal chronic hepatitis C after renal transplantation. Nephron 1995 0.77
84 Cholestatic jaundice in fascioliasis treated with niclofolan. Br Med J (Clin Res Ed) 1982 0.77
85 Hepatitis C in renal transplant recipients. Transplantation 1991 0.77
86 The impact of donor and recipient hepatitis B surface antigen status on liver disease and survival in renal transplant recipients. Transplantation 1992 0.77
87 Sucralfate versus cimetidine in duodenal ulcer--factors affecting healing and relapse. Scand J Gastroenterol Suppl 1987 0.76
88 Omeprazole and ranitidine in duodenal ulcer healing and subsequent relapse: a randomized double-blind study with weekly endoscopic assessment. J Gastroenterol Hepatol 1989 0.76
89 Combination therapy for chronic hepatitis B. Hepatology 1997 0.75
90 Clinical and histological features of delta infection in chronic hepatitis B virus carriers. J Clin Pathol 1985 0.75
91 Lamivudine therapy for chronic hepatitis B: is longer duration of treatment better? Gastroenterology 2000 0.75
92 Lamivudine treatment in patients with decompensated hepatitis B cirrhosis: for whom and when? J Hepatol 2000 0.75
93 Radiological diagnosis of leiomyosarcoma of the inferior vena cava. Clin Radiol 1986 0.75
94 Benign recurrent intrahepatic cholestasis in a Chinese girl. J Gastroenterol Hepatol 1991 0.75
95 Clinicopathologic features of hepatitis C virus infection in renal allograft recipients. Transplantation 1994 0.75
96 Response to hepatitis B vaccine in family members of HBsAg carriers. J Med Virol 1986 0.75
97 Longitudinal study of hepatitis C viremia in chronic hepatitis C. J Med Virol 1993 0.75
98 Reducing meal-stimulated acid secretion versus reducing nocturnal acid secretion for healing of duodenal ulcer. Dig Dis Sci 1989 0.75
99 Does OKT3 increase the risk of recurrent hepatitis B in patients transplanted for hepatitis B? Liver Transpl 2000 0.75
100 Histologic changes in Chinese patients with chronic hepatitis B virus infection after interferon-alpha therapy. Am J Clin Pathol 1992 0.75
101 Update of the Adult and Pediatric Liver Transplant Program at the University of Michigan. Clin Transpl 1996 0.75
102 A young man with a solitary hepatic mass. Hepatology 1995 0.75
103 Outcome of liver transplantation for hepatitis B: report of a single center's experience. Liver Transpl 2001 0.75
104 GBV-C and HGV: a new hepatitis virus? Gastroenterology 1996 0.75
105 Epidemiology and clinical course of delta infection in Britain. Prog Clin Biol Res 1983 0.75
106 Hepatitis C virus genotypes in patients on renal replacement therapy. Nephrol Dial Transplant 1998 0.75
107 Intrahepatic cholestasis associated with an enlarged gall-bladder. Med J Aust 1986 0.75
108 Hepatitis C after renal transplantation. Transplant Proc 2000 0.75
109 Life events and daily stress in duodenal ulcer disease. A prospective study of patients with active disease and in remission. Digestion 1992 0.75
110 Ultrasonographic studies in hepatic neoplasms: patterns and comparisons with radiological contrast studies. Clin Radiol 1985 0.75
111 Posttransplantation: future therapies. Semin Liver Dis 2000 0.75
112 Hepatitis C infection among renal transplant recipients: a comparative study using first- and second-generation anti-HCV EIA and HCV detection by nested PCR. Transplant Proc 1993 0.75